Tolterodine extended release is efficacious in continent and incontinent subjects with overactive bladder.
| Publicado en: | Urology Vol. 72; no. 3; pp. 488 - 494 |
|---|---|
| Autores principales: | , , , , |
| Formato: | clinical trial research Journal Article |
| Publicado: |
Elsevier B.V.
Sep2008
|
| Acceso en línea: | Ver este registro en EBSCOhost |
| fields | @attributes: recordID: 1 pdfLink: plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=105577739&site=ehost-live header: @attributes: shortDbName: ccm uiTerm: 105577739 longDbName: CINAHL Complete uiTag: AN controlInfo: bkinfo: dissinfo: jinfo: jid: 00904295 1YG jtl: Urology issn: 00904295 maglogo: N pubinfo: dt: Sep2008 vid: 72 iid: 3 pid: 467 pub: Elsevier B.V. place: New York, New York artinfo: ui: 105577739 2010105952 10.1016/j.urology.2008.05.019 NLM18639327 105577739 ppf: 488 ppct: 6 formats: tig: atl: Tolterodine extended release is efficacious in continent and incontinent subjects with overactive bladder. aug: au: Rovner ES Rackley R Nitti VW Wang JT Guan Z affil: Medical University of South Carolina, Charleston, South Carolina. sug: subj: Benzhydryl Compounds Therapeutic Use Muscarinic Antagonists Therapeutic Use Overactive Bladder Drug Therapy Phenols Therapeutic Use Phenylpropanolamine Therapeutic Use Urinary Incontinence Drug Therapy Aged Benzhydryl Compounds Administration and Dosage Delayed-Action Preparations Double-Blind Studies Female Male Middle Age Muscarinic Antagonists Administration and Dosage Phenols Administration and Dosage Phenylpropanolamine Administration and Dosage Placebos Time Factors Treatment Outcomes Urination Drug Effects Human Aged: 65+ years Middle Aged: 45-64 years Female Male pubtype: Academic Journal doctype: clinical trial research Journal Article ougenre: Article ab: language: English refInfo: holdings: @attributes: islocal: N |
|---|